Media, investors, advocacy organizations and others, please contact us here.
For US healthcare professionals only
The purpose of this Travere Therapeutics Medical Affairs website is to support healthcare professionals with scientific information. This website is also a channel for US healthcare professionals to submit questions or connect with Travere Therapeutics US healthcare professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US healthcare professional
The Dual Endothelin Angiotensin Receptor Antagonist (DEARA) Sparsentan Protects From Glomerular Hypercellularity and Associated Immune/Inflammatory Gene-Network- Activity in a Model of IgA Nephropathy
The Dual Endothelin Angiotensin Receptor Antagonist (DEARA) Sparsentan Protects From Glomerular Hypercellularity and Associated Immune/Inflammatory Gene-Network- Activity in a Model of IgA Nephropathy
Sparsentan, the dual endothelin and angiotensin receptor antagonist (DEARA), improves kidney function and lifespan and protects against hearing loss in Alport mice with developed renal structural changes
A Retrospective Analysis of Cardiovascular Disease (CVD) Events and All-cause Mortality in Prevalent Patients with Focal Segmental Glomerulosclerosis (FSGS) in the US
A Retrospective Analysis of Cardiovascular Disease (CVD) Events and All-cause Mortality in Prevalent Patients with Focal Segmental Glomerulosclerosis (FSGS) in the US